AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 1, 2025
The Central Drugs Standard Control Organisation (CDSCO) has sought the industry to start submitting the applications for clinical trial site addition and change of principal investigator through online mode, as part of streamlining the regulatory submission procedure.
Pharmaceutical Commerce
JANUARY 1, 2025
This bucket of Pharma Commerce coverage is highly powered by digital solutions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trialfacts
JANUARY 1, 2025
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center Research Center: UVA Health with Myriad Genetics Location: This is a study recruiting in Virginia and Maryland Lead Researcher: Dr. Jennifer L. Payne IRB: This study has been reviewed and approved by the University of Virginia Institutional Review Board HSR230396 About the Study How does pregnancy affect the way antidepressants work?
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 1, 2025
(Sean Anthony Eddy/Getty Images) COVID emerged suddenly, spread rapidly and killed millions of people around the world. Since then, I think it’s fair to say that most people have been nervous about the emergence of the next big infectious disease be that a virus, bacterium, fungus or parasite.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Law Blog
JANUARY 1, 2025
By Sara W. Koblitz Since the induced infringement finding in GSK v. Teva , the generic industry has feared the death of the skinny label (admittedly stoked by alarmist headlines like my own, see Ding Dong is the Skinny Label (Effectively) Dead? ). This is because, at a minimum, if a skinny-labeled generic is the basis for induced infringement liability, generic manufacturers will certainly think twice about using the skinny label process and still calling themselves AB-rated, which ultimately w
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 1, 2025
India is playing an increasingly significant role in the global MedTech sector. As the demand for medical technologies rises, especially in emerging markets, India is well-positioned to meet these needs through its vast manufacturing capacity and innovative solutions, said Arpit Paliwal, director, HRS Navigation.
Expert insights. Personalized for you.
140 
Let's personalize your content